News

Sant Pau starts one of the first two studies promoted by the ISCIII to fight against the COVID-19

The trial will study the use of hydroxychloroquine and azithromycin with or without tocilizumab and, among other objectives, whether these drugs reduce in-hospital mortality and the need for mechanica...

Sant Pau Research Institute publishes Metabolism

Researchers from the Lipids and Cardiovascular Pathology Group, from the Institute of Research of Sant Pau - IIB Sant Pau, led by Dr. Vicenta Llorente; from CSIC; from the Germans Trias i Pujol Resear...

Postponement of activities in Sant Pau

Following the guidelines of the Ministry of Health regarding preventive measures of an organizational nature to prevent the spread of the SARS-CoV-2 infection, the Research Institute of the Hospital d...

Matti Jauhiainen will give the next IIB Sant Pau seminar

The Sant Pau Institute for Biomedical Research - IIB Sant Pau with Dr. J. Carlos Escolà of the Research Group on Metabolic Bases in Cardiovascular Risk, organized the seminar "Transcription factor US...

Professor Gursky will give the next IIB Sant Pau seminar

The Sant Pau Biomedical Research Institute (IIB Sant Pau) with the Cardiovascular Biochemistry Research Group, led by Dr. José Luis Sánchez-Quesada, is organizing the seminar "Serum Amyloid A in Lip...